These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 24429300

  • 1. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J, Qiu LJ, Hu LF, Cen H, Zhang M, Wen PF, Wang XS, Pan HF, Ye DQ.
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [Abstract] [Full Text] [Related]

  • 2. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L, Faurschou M, Mogensen M, Jacobsen S.
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [Abstract] [Full Text] [Related]

  • 3. Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    Shang W, Ning Y, Xu X, Li M, Guo S, Han M, Zeng R, Ge S, Xu G.
    PLoS One; 2015 Oct; 10(5):e0126016. PubMed ID: 25973882
    [Abstract] [Full Text] [Related]

  • 4. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
    Onishi A, Sugiyama D, Kumagai S, Morinobu A.
    Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
    [Abstract] [Full Text] [Related]

  • 5. A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.
    Huang HB, Jiang SC, Han J, Cheng QS, Dong CB, Pan CM.
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1067-73. PubMed ID: 24525705
    [Abstract] [Full Text] [Related]

  • 6. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.
    Apor E, O'Brien J, Stephen M, Castillo JJ.
    Leuk Res; 2014 Sep; 38(9):1067-71. PubMed ID: 25052307
    [Abstract] [Full Text] [Related]

  • 7. Systemic lupus erythematous and malignancy risk: a meta-analysis.
    Cao L, Tong H, Xu G, Liu P, Meng H, Wang J, Zhao X, Tang Y, Jin J.
    PLoS One; 2015 Sep; 10(4):e0122964. PubMed ID: 25885411
    [Abstract] [Full Text] [Related]

  • 8. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A.
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased risk of malignancy in patients with systemic lupus erythematosus.
    Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, Manzi S.
    J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
    [Abstract] [Full Text] [Related]

  • 11. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E, Voulgarelis M, Moutsopoulos HM.
    Arch Intern Med; 2005 Nov 14; 165(20):2337-44. PubMed ID: 16287762
    [Abstract] [Full Text] [Related]

  • 12. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R, Zobbe K, Cordtz R, Haugaard JH, Dreyer L.
    Lupus; 2021 Apr 14; 30(5):752-761. PubMed ID: 33497306
    [Abstract] [Full Text] [Related]

  • 13. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus.
    Yeo J, Seo MS, Hwang IC, Shim JY.
    Arch Iran Med; 2020 Sep 01; 23(9):614-620. PubMed ID: 32979908
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High incidence of independent second malignancies after non-muscle-invasive bladder cancer.
    Zecha H, Schmid HP, Tschopp A, Sulser T, Engeler DS.
    Scand J Urol Nephrol; 2011 Sep 01; 45(4):245-50. PubMed ID: 21443417
    [Abstract] [Full Text] [Related]

  • 18. Systemic lupus erythematosus and malignancies risk.
    Mao S, Shen H, Zhang J.
    J Cancer Res Clin Oncol; 2016 Jan 01; 142(1):253-62. PubMed ID: 26319223
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.